Nanchang, March 9, 2026 – Nanchang witnessed a grand event focused on innovation and development today – the 2026 Nanchang City Deepening Promotion of the "8810" Action Plan and Technological Innovation and Development Conference. Hosted by the Nanchang Municipal Committee of the Communist Party of China and the Nanchang Municipal People's Government, the conference gathered leading figures and innovative forces from the city's key industrial chains.

At this high-profile conference, Nanchang Huaan Zhonghui Health Technology Co., Ltd. (hereinafter referred to as "Huaan Zhonghui") was officially recognized by the Nanchang Municipal Committee of the Communist Party of China and the Nanchang Municipal People's Government as a "2025 Excellent and Strong Enterprise in a Key Manufacturing Industry Chain." This honor not only affirms Huaan Zhonghui's high-quality development over the past year but also stands as authoritative recognition of its pioneering role in Nanchang's biomedical industry chain.

Deeply Rooted in Nanchang, Setting the "Innovation Benchmark" in the Surgical Field
Huaan Zhonghui is a national-level "Little Giant" enterprise specializing in new and sophisticated technologies. As the first enterprise in Jiangxi Province to produce high-frequency electrosurgical consumables, Huaan Zhonghui has firmly adhered to an "innovation-first" development strategy since its establishment in 2010. On the fertile ground for innovation in Nanchang High-tech Zone, it has gradually grown into a leader in the domestic high-frequency electrosurgical medical device market. Recently, the company's innovative project won the second prize in the national finals of the 10th "Maker China" SME Innovation and Entrepreneurship Competition, with its technology being identified as a "world-first."
"Good electrosurgical devices, made in Nanchang." This widely circulated praise within the industry is not only market recognition of Huaan Zhonghui's products but also a vivid reflection of an enterprise embedding innovation into its core. The "Excellent and Strong Enterprise" title is awarded not only because Huaan Zhonghui has generated considerable economic benefits but also because it has redefined the value dimension of medical device innovation – anchoring innovation in clinical practice and letting technology serve life.
In the medical field, a millisecond's response time, a single degree of precise temperature control, and the optimized design of a minimally invasive incision directly impact patients' postoperative quality of life. Huaan Zhonghui's R&D logic is not about accumulating lab parameters in isolation but involves entering the operating room and working side-by-side with surgeons. From the smooth operation of the Ruisi Ablation Electrode in fine neurosurgical dissection to the minimized tissue damage caused by Bonny Medical's minimally invasive instruments during laparoscopy, the iterative upgrade of each product stems from a profound insight into clinical pain points. This ultimately translates into faster postoperative recovery, smaller scars, and lower complication risks for patients. This closed loop of innovation – originating from and giving back to the clinic – is the most vivid manifestation of new productive forces in the healthcare sector.
As a core enterprise in Nanchang's biomedical industry chain, Huaan Zhonghui deeply understands that the "excellence" of an "Excellent and Strong Enterprise" lies in continuously breaking through technological barriers, and its "strength" lies in driving and radiating impact throughout the industry chain. Leveraging Nanchang's favorable policies like the "Talent 10 Articles" and in-depth collaboration with top-tier clinical resources such as the Cancer Hospital of the Chinese Academy of Medical Sciences, Tiantan Hospital, West China Hospital, and the First Affiliated Hospital of Gannan Medical University, Huaan Zhonghui is striving to build an integrated innovation ecosystem for surgical instruments combining industry, academia, research, and application. From the application of new upstream materials to the upgrading of precision manufacturing processes, the company has not only achieved self-reliance and control over core components but has also spurred the coordinated development of supporting enterprises in the regional industrial chain, gradually highlighting the cluster effect of "Made in Nanchang" high-end medical devices.

Dual-Brand Drive, Aiming to Become a Leader in the Field of Surgical Instruments
Currently, the company operates two core brands, Ruisi and Bonny Medical, forming a relatively comprehensive product matrix covering open surgery and minimally invasive endoscopic procedures:

Ruisi Brand: Focuses on the high-frequency electrosurgery field. Core products include Ablation Electrodes, Multifunctional Surgical Dissectors, Multifunctional Surgical Dissection Cutters, Radiofrequency Ablation Electrodes, Dilators, Patient Return Electrodes (Neutral Electrodes), and compatible main units. Among these, the flagship product "Ruisi Ablation Electrode" has benefited numerous patients nationwide and holds a leading position in niche markets such as head and neck, thyroid, and neurosurgery.

Bonny Medical: Specializes in minimally invasive surgical instruments. The product line comprehensively covers laparoscopes, high-frequency surgical instruments, intelligent staplers, stapling devices, trocars, sutures, ligation clips, clip appliers, grasping forceps, endoscopic scissors, and surgical retractor/fixation devices. The establishment of the Bonny brand marks Huaan Zhonghui's transition from an "electrosurgical consumables supplier" to a "provider of comprehensive surgical solutions."

Looking to the Future: Combining International Ambition with Social Responsibility
Looking ahead, Huaan Zhonghui's mission extends beyond commercial progress to encompass a profound sense of social responsibility. Against the backdrop of increasingly fierce competition in the global medical device market, Huaan Zhonghui is actively advancing its internationalization strategy, backed by its "world-first" technological prowess. This is not only a necessary path for the company to seek broader markets but also a proactive attempt to introduce Chinese surgical solutions and "Intelligent Manufacturing in China" standards to the world stage.
Honors testify to the past, while endeavor defines the future. Standing at this new starting point as an "Excellent and Strong Enterprise," Huaan Zhonghui will continue to delve deeper into the fields of minimally invasive surgery and high-frequency electrosurgery. With more original and leading innovative achievements, it will persistently polish the "Made in Nanchang" medical brand, contribute to the "Healthy China" initiative, and ensure that behind the precision and safety of every operation lies Nanchang's wisdom, safeguarding the spark of life.